Eliza Kruger is a Director of Global Health Economics and Outcomes Research (HEOR) at Ultragenyx and an expert in HEOR. She is passionate about supporting better, evidence-based decision-making in healthcare, particularly in rare diseases. She has 10 years of experience in academia, consulting and pharmaceutical industry in Singapore and the United States. She is originally from Australia, where she completed her undergraduate in Economics and Master of Health Economics.
